TRIANA Biomedicines - About the company
TRIANA Biomedicines is a series B company based in Waltham (United States), founded in 2021 by Jesse Chen. It operates as a Developer of precision medicine for the treatment of cancer. TRIANA Biomedicines has raised $163M in funding from investors like Lightspeed Venture Partners, Bessemer Venture Partners and Ascenta Capital, with a current valuation of $*****. The company has 3243 active competitors, including 1118 funded and 773 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, BeiGene and Sana Biotechnology.
Company Details
Developer of precision medicine for the treatment of cancer. The company has a molecular glue discovery platform to regulate disease targets powered by high-resolution structural insights, and computational tools for cancer indications.
- Website
- trianabio.com
- Social
- Email ID
- *****@trianabio.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2021
Location
Waltham, United States
Stage
Series B
Total Funding
$163M in 2 rounds
Latest Funding Round
Post Money Valuation
$***** as on Sep 12, 2024
Investors
Ranked
127th among 3243 active competitors
Employee Count
62 as on Jun 30, 2026
Similar Companies
Sign up to download TRIANA Biomedicines' company profile
TRIANA Biomedicines's funding and investors
TRIANA Biomedicines has raised a total funding of $163M over 2 rounds. Its first funding round was on Apr 06, 2022. Its latest funding round was a Series B round on Nov 26, 2025 for $*****. 11 investors participated in its latest round. TRIANA Biomedicines has 13 institutional investors.
Here is the list of recent funding rounds of TRIANA Biomedicines:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 26, 2025 | 3366605 | Series B | 6008076 | 5445122 | 3164861 | 8063179 |
Apr 06, 2022 | 8986963 | Series A | 7443580 | 8035106 |
Access funding benchmarks and valuations. Sign up today!View details of TRIANA Biomedicines's funding rounds and investors
TRIANA Biomedicines' founders and board of directors
Founder? Claim ProfileThe founders of TRIANA Biomedicines is Jesse Chen.
Here are the details of TRIANA Biomedicines' key team members:
- Jesse Chen: Co-Founder & Chief Technology Officer of TRIANA Biomedicines and founder of 1 other company.
View details of TRIANA Biomedicines's Founder profiles and Board Members
TRIANA Biomedicines' employee count trend
TRIANA Biomedicines has 62 employees as of Jun 26. Here is TRIANA Biomedicines's employee count trend over the years:
Uncover TRIANA Biomedicines' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
TRIANA Biomedicines's Competitors and alternates
Top competitors of TRIANA Biomedicines include Jazz Pharmaceuticals, BeiGene and Sana Biotechnology. Here is the list of Top 10 competitors of TRIANA Biomedicines, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Jazz Pharmaceuticals 2003, Dublin (Ireland), Public | Developer of novel biopharmaceutical medicines for unmet medical needs | $265M | 82/100 | |
2nd |  BeiGene 2010, Cambridge (United States), Public | Developer of targeted and immune-oncology drugs against cancer | $172M | 80/100 | |
3rd |  Sana Biotechnology 2018, Seattle (United States), Public | Developer of engineered cell therapies for treating various human diseases | $821M | 75/100 | |
4th | Senti Bio 2016, San Francisco (United States), Public | Developer of cell and gene therapies for patients living with incurable diseases | $158M | 72/100 | |
5th | Ideaya Biosciences 2015, San Francisco (United States), Public | Developer of oncology-focused precision medicine using molecular diagnostics | $157M | 72/100 | |
6th | Sutro Biopharma 2003, United States, Public | Developer of antibody-based therapeutics for cancer therapy | $175M | 72/100 | |
7th | Syndax 2005, Waltham (United States), Public | Developer of targeted therapies for the treatment of cancer | $198M | 72/100 | |
8th |  Moderna 2010, Cambridge (United States), Public | Developer of mRNA-based therapeutics for a wide range of diseases | $2.78B | 71/100 | |
9th | Karyopharm 2008, Newton (United States), Public | Biopharmaceutical company focused on developing and commercializing innovative cancer therapies | $98.4M | 71/100 | |
10th | Developer of T-cell therapies for the treatment of cancer | $49.8M | 71/100 | ||
127th |  TRIANA Biomedicines 2021, Waltham (United States), Series B | Developer of precision medicine for the treatment of cancer | $163M | 57/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on TRIANA Biomedicines's competitors? Click here to see the top ones
TRIANA Biomedicines's Investments and acquisitions
TRIANA Biomedicines has made no investments or acquisitions yet.
Reports related to TRIANA Biomedicines
Here is the latest report on TRIANA Biomedicines's geography:
News related to TRIANA Biomedicines
Media has covered TRIANA Biomedicines for a total of 5 events in the last 1 year, 2 of them have been about company updates and 1 about people movement.
•
•
•
TRIANA Biomedicines' TRI-611 Receives FDA Fast Track DesignationBusiness Wire•Mar 25, 2026•TRIANA Biomedicines
•
•
•
•
•
•
Triana’s $110 Million Series A FinancingGlobal Legal Chronicle•Apr 15, 2022•TRIANA Biomedicines, Gunderson Dettmer, Lightspeed Venture Partners
•
Triana Biomedicines Raises $110M In Series A FundingFinSMEs•Apr 09, 2022•TRIANA Biomedicines, Lightspeed Venture Partners, Pfizer, Citadel and 1 other
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about TRIANA Biomedicines
Explore our recently published companies
- FinLead AI - Delhi based, 2025 founded, Unfunded company
- Sylcloud - Unfunded company
- Ppbtechnology - 2017 founded, Unfunded company
- Opulancetechnologies - Unfunded company
- Starcgreen - Unfunded company
- World Wall - Overland Park based, 2016 founded, Unfunded company
